"Gilead Records a First" against AIDS: Tenofovir (Viread) is 100% Effective in AIDS Model; Interview with Gilead CEO Michael L Riordan and NIH Officials
Gilead's breakthrough drug candidate PMPA [tenofovir, Viread, constituent of Truvada], shows 100% protection in an NIH-sponsored monkey model of AIDS. Interviewees include Dr Anthony Fauci of NIAID; Dr Michael Riordan, Gilead's founder and CEO; Dr Roberta Black of NIH. “Such complete protection with no toxicity is unprecedented in the monkey model of AIDS,” said Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases. 1995.
"Gilead Records a First" against AIDS: Tenofovir (Viread) is 100% Effective in AIDS Model; Interview with Gilead CEO Michael L Riordan and NIH Officials